Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development),
type b, 1 - CISMeF
Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development),
type b, 1OMIM Phenotype
Preferred Label : Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development),
type b, 1;
Symbol : MDDGB1;
CISMeF acronym : MDDGB1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Muscular dystrophy, congenital, pomt1-related;
Description : Congenital muscular dystrophies resulting from defective glycosylation of alpha-dystroglycan
(DAG1; 128239) are characterized by early onset of muscle weakness, usually before
ambulation is achieved; mental retardation and mild brain anomalies are variable (Balci
et al., 2005; Godfrey et al., 2007). Congenital muscular dystrophy-dystroglycanopathies
with or without mental retardation (type B) represent the intermediate range of the
spectrum of dystroglycanopathies. They are less severe than muscular dystrophy-dystroglycanopathy
with brain and eye anomalies (type A; see;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the protein O-mannosyltransferase-1 gene (POMT1, 607423.0006);